Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation
Open accessAbstract
// Xianmin Mu 1, * , Ting Zhao 1, * , Che Xu 1 , Wei Shi 4 , Biao Geng 1 , Jiajia Shen 2 , Chen Zhang 1 , Jinshun Pan 1 , Jing Yang 1 , Shi Hu 1 , Yuanfang Lv 1 , Hao Wen 2 , Qiang You 1, 3 1 Department of Biotherapy, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210011, China 2 Department of Surgery, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210011, China 3 Department of Immunology, Nanjing Medical University, Nanjing, Jiangsu 211166, China 4 Department of Drug Screening and Evaluation, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, Jiangsu 210023, China * These authors have contributed equally to this work Correspondence to: Qiang You, email: Qiang.You@njmu.edu.cn Keywords: succinate, GPR91, gastric cancer, angiogenesis, ERK1/2 Received: October 20, 2016 Accepted: December 23, 2016 Published: January 04, 2017 ABSTRACT Altered cellular metabolism is now generally acknowledged as a hallmark of cancer cells, the resultant abnormal oncometabolites cause both metabolic and nonmetabolic dysregulation and potential transformation to malignancy. A subset of cancers have been found to be associated with mutations in succinate dehydrogenase genes which result in the accumulation of succinate. However, the function of succinate in tumorigenesis remains unclear. In the present study, we aim to investigate the role of oncometabolite succinate in tumor angiogenesis. Our data demonstrated the accumulation of markedly elevated succinate in gastric cancer tissues compared with that in paracancerous tissues. Moreover, succinate was able to increase the chemotactic motility, tube-like structure formation and proliferation of primary human umbilical vascular endothelial cells (pHUVECs) in vitro , as well as promoting the blood vessel formation in transgenic zebrafish. Our mechanistic studies reveal that succinate upregulates vascular endothelial growth factor (VEGF) expression by activation of signal transducer and activator of transcription 3 (STAT3) and extracellular regulated kinase (ERK)1/2 via its receptor GPR91 in a HIF-1α independent mechanism. Taken together, these data indicate an important role of the succinate-GPR91 axis in tumor angiogenesis, which may enable development of a novel therapeutic strategy that targets cancer metabolism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Loss of HIF-1α in macrophages decreases TNF-α, IL-1β and IL-1α production but does not affect production of IL-4 or IL-10.
“The loss of HIF-1α in macrophages decreased TNF-α, IL-1β and IL-1α production, but did not affect production of the anti-inflammatory cytokines IL-4 or IL-10 29.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · see citing works
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · see citing works
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1× · see citing works
“For example, succinate accumulates in succinate dehydrogenase-deficient tumors like gastrointestinal stromal tumors (GIST), inhibits prolyl hydroxylase activity with subsequent HIF-1α stabilization and therefore drives cancer progression [11, 12].”
BackgroundEndothelial Cell Migration During Angiogenesis
Lamalice, L., Bœuf, F. L., & Huot, J. (2007) · Circulation Research · doi:10.1161/01.res.0000259593.07661.1e · Cited by 1,486 · see citing works
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
He, W., Miao, F. J.-P., Lin, D. C.-H., Schwandner, R. T., Wang, Z., Gao, J., Chen, J.-L., Tian, H., & Ling, L. (2004) · Nature · doi:10.1038/nature02488 · Cited by 909 · cited 4× · see citing works
“G protein-coupled receptor-91 (GPR91), also known as succinate receptor 1 (SUCNR1) [10], is expressed in several highly vascularized tissues, including retina, heart, liver, kidney and white adipose tissue, and even on the surface of human monocyte-derived dendritic cells.”
BackgroundMethodInfluentialSuccinate: a metabolic signal in inflammation
Mills, E., & O’Neill, L. A. J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.008 · Cited by 741 · see citing works
Chung, J., Uchida, E., Grammer, T. C., & Blenis, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6508 · Cited by 620 · see citing works
Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536 · see citing works
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity
Rubic, T., Lametschwandtner, G., Jost, S., Hinteregger, S., Kund, J., Carballido-Perrig, N., Schwärzler, C., Junt, T., Voshol, H., Meingassner, J. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1657 · Cited by 525 · see citing works
Inhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates
Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610415200 · Cited by 521 · see citing works
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis.
Tretter, L., Patócs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta · doi:10.1016/j.bbabio.2016.03.012 · Cited by 502 · see citing works
Oncometabolites: linking altered metabolism with cancer
Yang, M. H., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 424 · see citing works
The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis
Sapieha, P., Sirinyan, M., Hamel, D., Zaniolo, K., Joyal, J.-S., Cho, J.-H., Honoré, J.-C., Kermorvant-Duchemin, E., Varma, D. R., Tremblay, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1873 · Cited by 359 · see citing works
Self-citationMavria, G., Vercoulen, Y., Yeo, M., Paterson, H., Karasarides, M., Marais, R., Bird, D., & Marshall, C. J. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.021 · Cited by 335 · see citing works
STAT3: A critical transcription activator in angiogenesis
Chen, Z., & Han, Z. (2007) · Medicinal Research Reviews · doi:10.1002/med.20101 · Cited by 302 · see citing works
Familial Gastrointestinal Stromal Tumors and Germ-Line Mutations
McWhinney, S. R., Pasini, B., & Stratakis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071191 · Cited by 224 · see citing works
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 177 · see citing works
Kushnir, M. M., Komaromy-Hiller, G., Shushan, B. I., Urry, F. M., & Roberts, W. L. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.11.1993 · Cited by 170 · see citing works
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161 · see citing works
Activation of the Succinate Receptor GPR91 in Macula Densa Cells Causes Renin Release
Vargas, S. L., Toma, I., Kang, J. J., Meer, E. J., & Peti‐Peterdi, J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070740 · Cited by 153 · see citing works
Succinate is a paracrine signal for liver damage
Correa, P. R. A. V., Kruglov, E. A., Thompson, M., Leite, M. F., Dranoff, J. A., & Nathanson, M. H. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.016 · Cited by 151 · see citing works
Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
Ehinger, J. K., Piel, S., Ford, R., Karlsson, M., Sjövall, F., Frostner, E. Å., Morota, S., Taylor, R. W., Turnbull, D. M., Cornell, C. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12317 · Cited by 144 · see citing works
Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish
Bayliss, P. E., Bellavance, K. L., Whitehead, G. G., Abrams, J., Aegerter, S., Robbins, H. S., Cowan, D. B., Keating, M. T., O’Reilly, T., Wood, J. M., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio778 · Cited by 138 · see citing works
Targeted Disruption of the SUCNR1 Metabolic Receptor Leads to Dichotomous Effects on Obesity
McCreath, K. J., Espada, S., Gálvez, B. G., Benito, M., de Molina-Iracheta, A., Sepúlveda, P., & Cervera, A. M. (2014) · Diabetes · doi:10.2337/db14-0346 · Cited by 120 · see citing works
Robben, J. H., Fenton, R. A., Vargas, S. L., Schweer, H., Peti‐Peterdi, J., Deen, P. M. T., & Milligan, G. (2009) · Kidney International · doi:10.1038/ki.2009.360 · Cited by 113 · see citing works
Mukhopadhyay, D., Nagy, J. A., Manseau, E. J., & Dvorak, H. F. (1998) · PubMed · Cited by 92 · see citing works
Genetically-defined metabolic reprogramming in cancer
Mullen, A. R., & DeBerardinis, R. J. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.009 · Cited by 87 · see citing works
Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
Mu, X., Shi, W. Q., Sun, L., Han, L., Jiang, Z., & Zhang, L. (2012) · Molecules · doi:10.3390/molecules17066854 · Cited by 52 · see citing works
Self-citationThe MAPK signaling pathway mediates the GPR91-dependent release of VEGF from RGC-5 cells
HU, J., LI, T., DU, S., CHEN, Y., WANG, S., XIONG, F., & WU, Q. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2195 · Cited by 48 · see citing works
Wei, J., Zhang, J., Si, Y., Kanada, M., Zhang, Z., Terakawa, S., & Watanabe, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.032 · Cited by 30 · see citing works
Yang, L., Yu, D., Fan, H.-H., Yu, F., Hu, L., Zhang, W., Zhou, K., & Mo, X. (2014) · PubMed Central · Cited by 26 · see citing works
Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis
Song, K., Wu, H., Rahman, H. N. A., Dong, Y., Wen, A., Brophy, M. L., Wong, S., Kwak, S., Bielenberg, D. R., & Chen, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2347-2 · Cited by 16 · see citing works
pH-dependent impairment of the neutrophil respiratory burst by the Bacteroides byproduct succinate.
Od, R., Pe, N., & Grinstein, S. (1988) · PubMed · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mu, X., Shi, W. Q., Xu, Y., Xu, C., Zhao, T., Geng, B., Yang, J., Pan, J., Hu, S., Zhang, C., et al. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1444305 · Cited by 516 · see citing works
Self-citationCoupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 297 · see citing works
Oncometabolites in renal cancer
Yong, C., Stewart, G. D., & Frezza, C. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0210-z · Cited by 212 · see citing works
Regulation of succinate dehydrogenase and role of succinate in cancer
Dalla Pozza, E., Dando, I., Pacchiana, R., Liboi, E., Scupoli, M. T., Donadelli, M., & Palmieri, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.04.013 · Cited by 212 · see citing works
G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers
Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 147 · see citing works
CPT 1A‐mediated succinylation of S100A10 increases human gastric cancer invasion
Wang, C., Zhang, C., Li, X., Shen, J., Xu, Y., Shi, H. M., Mu, X., Pan, J., Zhao, T., Li, M., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13920 · Cited by 141 · see citing works
Self-citationCancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 138 · see citing works
Succinate: An initiator in tumorigenesis and progression
Zhao, T., Mu, X., & You, Q. (2017) · OncoTarget · doi:10.18632/oncotarget.17734 · Cited by 109 · see citing works
Self-citationHallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming
D’Alessandro, A., Kasmi, K. C. E., Plecitá‐Hlavatá, L., Ježek, P., Li, M., Zhang, H., Gupte, S. A., & Stenmark, K. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7217 · Cited by 110 · see citing works
STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects
Ashrafizadeh, M., Zarrabi, A., Orouei, S., Zarrin, V., Moghadam, E. R., Zabolian, A., Mohammadi, S., Hushmandi, K., Gharehaghajlou, Y., Makvandi, P., et al. (2020) · Biology · doi:10.3390/biology9060126 · Cited by 108 · see citing works
Rethinking succinate: an unexpected hormone-like metabolite in energy homeostasis
Fernández‐Veledo, S., Ceperuelo‐Mallafré, V., & Vendrell, J. J. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.06.003 · Cited by 106 · see citing works
Cancer-derived extracellular succinate: a driver of cancer metastasis
Kuo, C.-C., Wu, J.-Y., & Wu, K. K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00878-z · Cited by 104 · see citing works
Ocaña, M. C., Martı́nez-Poveda, B., Quesada, A. R., & Medina, M. Á. (2018) · Medicinal Research Reviews · doi:10.1002/med.21511 · Cited by 91 · see citing works
Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory
Collins, R. R. J., Patel, K., Putnam, W. C., Kapur, P., & Rakheja, D. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.267666 · Cited by 90 · see citing works
Liu, X., Si, W., Liu, X., He, L., Ren, J., Yang, Z., Yang, J., Li, W., Liu, S., Pei, F., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0744-2 · Cited by 80 · see citing works
Self-citationGómez, V., Eykyn, T. R., Mustapha, R., Flores‐Borja, F., Male, V. H., Barber, P. R., Patsialou, A., Green, R. J., Panagaki, F., Li, C. W., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax4585 · Cited by 76 · see citing works
Biomaterial‐Based Metabolic Regulation in Regenerative Engineering
Ma, C., Kuzma, M. L., Bai, X., & Yang, J. Y. (2019) · Advanced Science · doi:10.1002/advs.201900819 · Cited by 63 · see citing works
Self-citationThe role of the metabolite cargo of extracellular vesicles in tumor progression
Harmati, M., Bukva, M., Böröczky, T., Buzás, K., & Gyukity-Sebestyén, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10014-2 · Cited by 63 · see citing works
Ko, S. H., Choi, G. E., Oh, J. Y., Lee, H. J., Kim, J. S., Chae, C. W., Choi, D., & Han, H. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12692-x · Cited by 63 · see citing works
Li, J., Liang, N. N., Long, X., Zhao, J., Yang, J., Du, X., Yang, T., Yuan, P., Huang, X., Zhang, J., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.001 · Cited by 62 · see citing works
Self-citationInterleukin-6 induces drug resistance in renal cell carcinoma.
Ishibashi, K., Koguchi, T., Matsuoka, K., Onagi, A., Tanji, R., Takinami-Honda, R., Hoshi, S., Onoda, M., Kurimura, Y., Hata, J., et al. (2018) · Fukushima Journal of Medical Science · doi:10.5387/fms.2018-15 · Cited by 53 · see citing works
Ortiz‐Masiá, D., Gisbert-Ferrándiz, L., Bauset, C., Coll, S., Mamie, C., Scharl, M. M., Esplugues, J. V., Alós, R., Navarro, F., Cosín‐Roger, J., et al. (2020) · Cells · doi:10.3390/cells9051104 · Cited by 58 · see citing works
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy
Chen, C., Wang, Z., & Qin, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935536 · Cited by 60 · see citing works
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
van Niekerk, G., & Engelbrecht, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0383-7 · Cited by 57 · see citing works
The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57 · see citing works
GPR91, a critical signaling mechanism in modulating pathophysiologic processes in chronic illnesses
Li, X., Xie, L. H., Qu, X., Zhao, B., Fu, W., Wu, B., & Wu, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001037r · Cited by 48 · see citing works
Oncometabolites in cancer aggressiveness and tumour repopulation
Dando, I., Pozza, E. D., Ambrosini, G., Torrens‐Mas, M., Butera, G., Mullappilly, N., Pacchiana, R., Palmieri, M., & Donadelli, M. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12513 · Cited by 49 · see citing works
Extracellular Succinate: A Physiological Messenger and a Pathological Trigger
Wu, K. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311165 · Cited by 46 · see citing works
Hu, L., Cui, R., Liu, H., & Wang, F. (2017) · Oncotarget · doi:10.18632/oncotarget.21330 · Cited by 45 · see citing works
Zhu, M., Liu, X., Wang, Y., Chen, L., Wang, L., Qin, X., Xu, J., Li, L., Tu, Y., Zhou, T., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.10.007 · Cited by 45 · see citing works
Succinate at the Crossroad of Metabolism and Angiogenesis: Roles of SDH, HIF1α and SUCNR1
Atallah, R., Olschewski, A., & Heinemann, Á. (2022) · Biomedicines · doi:10.3390/biomedicines10123089 · Cited by 43 · see citing works
Liao, S., Han, L., Zheng, X., Wang, X., Zhang, P., Wu, J., Liu, R., Fu, Y.-L., Sun, J., Kang, X., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14714 · Cited by 43 · see citing works
Metabolic Signaling in Cancer Metastasis
Krieg, S., Fernandes, S. I., Kolliopoulos, C., Liu, M., & Fendt, S. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0174 · Cited by 41 · see citing works
Gao, Y., Qian, H., Xue Ming, T. A. N. G., Du, X., Wang, G., Zhang, H., Ye, F., & Liu, T. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200480 · Cited by 41 · see citing works
Verma, A., & Lindroth, A. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01537-7 · Cited by 43 · see citing works
Matlac, D. M., Vanova, K. H., Bechmann, N., Richter, S., Inderhees, J., Ghayee, H. K., Ge, G., Abunimer, L., WESLEY, R. A., Aherrahrou, R., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.589451 · Cited by 40 · see citing works
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
Taïeb, D., & Pacák, K. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.08.001 · Cited by 39 · see citing works
Succinate Dehydrogenase–Deficient Renal Cell Carcinoma: A Short Review
Wang, G., & Rao, P. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0199-rs · Cited by 38 · see citing works
Chen, Y., Chen, X., Ding, X., & Wang, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10562 · Cited by 37 · see citing works
Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
Baryła, M., Semeniuk-Wojtaś, A., Róg, L., Kraj, L., Małyszko, M., & Stec, R. (2022) · Biology · doi:10.3390/biology11020270 · Cited by 39 · see citing works
Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?
Cosín‐Roger, J., Ortiz‐Masiá, D., Barrachina, M. D., & Calatayud, S. (2020) · Cells · doi:10.3390/cells9112345 · Cited by 36 · see citing works
Molecular pathogenesis of tumorigenesis caused by succinate dehydrogenase defect
Moosavi, B., Zhu, X., Yang, W., & Yang, G. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.151057 · Cited by 36 · see citing works
Succinate receptor 1 inhibits mitochondrial respiration in cancer cells addicted to glutamine
Rabe, P., Liebing, A., Krumbholz, P., Kraft, R., & Stäubert, C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.024 · Cited by 33 · see citing works
Sabadell‐Basallote, J., Astiarraga, B., Castaño, C., Ejarque, M., Repollés-de-Dalmau, M., Quesada, I., Blanco, J., Núñez‐Roa, C., Rodríguez‐Peña, M., Martínez, L., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci173214 · Cited by 32 · see citing works
Lopes‐Coelho, F., Nunes, C., Gouveia-Fernandes, S., Rosas, R., SILVA, F. A. B. N. D., Gameiro, P., Carvalho, T., da Silva, M. G., Cabeçadas, J., Dias, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20294 · Cited by 32 · see citing works
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 33 · see citing works
Soumoy, L., Schepkens, C., Krayem, M., Najem, A., Tagliatti, V., Ghanem, G., Saussez, S., Colet, J., & Journé, F. (2020) · Cancers · doi:10.3390/cancers12051323 · Cited by 30 · see citing works
Löffler, J., Noom, A., Ellinghaus, A., Dienelt, A., Kempa, S., & Duda, G. N. (2023) · Communications Biology · doi:10.1038/s42003-023-04652-1 · Cited by 30 · see citing works
Oncometabolites and the response to radiotherapy
Xiang, K., Jendrossek, V., & Matschke, J. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01638-9 · Cited by 29 · see citing works
Bauset, C., Lis-López, L., Coll, S., Gisbert-Ferrándiz, L., Macias-Ceja, D. C., Seco-Cervera, M., Navarro, F., Esplugues, J. V., Calatayud, S., Ortiz‐Masiá, D., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030532 · Cited by 28 · see citing works
Oncometabolites in cancer: from cancer cells to the tumor microenvironment
Chen, L., & Huang, M. (2024) · Holistic Integrative Oncology · doi:10.1007/s44178-024-00096-7 · Cited by 27 · see citing works
Metabolic Signaling in the Tumor Microenvironment
Clay, R., Li, K., & Jin, L. (2025) · Cancers · doi:10.3390/cancers17010155 · Cited by 31 · see citing works
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Uher, O., Vanova, K. H., Taïeb, D., Calsina, B., Robledo, M., Clifton-Bligh, R. J., & Pacák, K. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae005 · Cited by 29 · see citing works
Cancer Alters the Metabolic Fingerprint of Extracellular Vesicles
Palviainen, M., Laukkanen, K., Tavukcuoglu, Z., Velagapudi, V., Kärkkäinen, O. K., Hanhineva, K., Auriola, S. O. K., Ranki, A., & Siljander, P. R. M. (2020) · Cancers · doi:10.3390/cancers12113292 · Cited by 25 · see citing works
Terra, X., Ceperuelo‐Mallafré, V., Linares, C. M., Benaiges, E., Bosch, R., Castillo, P., Flores, J. C., León, X., Valduvieco, I., Basté, N., et al. (2021) · Cancers · doi:10.3390/cancers13071653 · Cited by 25 · see citing works
Tumour microenvironment in pheochromocytoma and paraganglioma
Martinelli, S., Amore, F., Canu, L., Maggi, M., & Rapizzi, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1137456 · Cited by 26 · see citing works
Atallah, R., Gindlhuber, J., Platzer, W., Bärnthaler, T., Tatzl, E., Toller, W. G., Strutz, J., Rittchen, S., Luschnig, P., Birner‐Gruenberger, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112048 · Cited by 23 · see citing works
The prowess of metabolomics in cancer research: current trends, challenges and future perspectives
Taunk, K., Jajula, S., Bhavsar, P. P., Choudhari, M., Bhanuse, S. G., Tamhankar, A. S., Naiya, T., Kalita, B., & Rapole, S. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05041-w · Cited by 23 · see citing works
Zhang, M., Wu, D., Xu, J. H., Liu, L., Jiao, W., Yu, J., & Chen, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.884881 · Cited by 23 · see citing works
Casas-Benito, A., Martínez-Herrero, S., & Martı́nez, A. (2023) · Cancers · doi:10.3390/cancers15102862 · Cited by 25 · see citing works
Zhang, H., Zheng, J., Lin, J., Chen, J., Yu, Z., Chen, C., & Liu, T. (2018) · Gene · doi:10.1016/j.gene.2018.04.029 · Cited by 23 · see citing works
SDH defective cancers: molecular mechanisms and treatment strategies
Wang, J., Yuan, T., Yang, B. W., He, Q., & Zhu, H. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10022-w · Cited by 24 · see citing works
Boedtkjer, E. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_63 · Cited by 22 · see citing works
Wu, D., Xu, J. H., Jiao, W., Liu, L., Yu, J., Zhang, M., & Chen, G. (2023) · Molecules · doi:10.3390/molecules28041551 · Cited by 22 · see citing works
Sutera, A. M., Riggio, V., Mastrangelo, S., Gerlando, R. D., Sardina, M. T., Pong‐Wong, R., Tolone, M., & Portolano, B. (2019) · Animal Genetics · doi:10.1111/age.12789 · Cited by 20 · see citing works
TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/HIF1α dependent manner
Xu, Y., Li, Y., Chen, X., Xiang, F., Deng, Y., Zhong, L., & Wei, D. (2021) · BMC Cancer · doi:10.1186/s12885-021-08954-7 · Cited by 20 · see citing works
Fratev, F., Gutiérrez, D. A., Aguilera, R. J., Tyagi, A., Damodaran, C., & Sirimulla, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1715835 · Cited by 17 · see citing works
Nutritional and metabolic signalling through GPCRs
Pardella, E., Ippolito, L., Giannoni, E., & Chiarugi, P. (2022) · FEBS Letters · doi:10.1002/1873-3468.14441 · Cited by 17 · see citing works
Garimella, S. V., Gampa, S. C., & Chaturvedi, P. (2023) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s417842 · Cited by 15 · see citing works
Metabolic requirements of the metastatic cascade
Drápela, S., & Gomes, A. P. (2021) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2021.100381 · Cited by 14 · see citing works
Yu, J., Yang, H., Zhang, L., Ran, S., Shi, Q., Peng, P., Liu, Q., & Song, L. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03195-x · Cited by 14 · see citing works
Model systems in SDHx-related pheochromocytoma/paraganglioma
Takács‐Vellai, K., Farkas, Z., Ősz, F., & Stewart, G. W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10009-z · Cited by 16 · see citing works
Cedó, L., Madeira, A., & Caro, P. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.10.007 · Cited by 12 · see citing works
Farrokhnia, M., Babamiri, B., Mohammadi, M., & Sanati‐Nezhad, A. (2025) · ACS Sensors · doi:10.1021/acssensors.5c00355 · Cited by 12 · see citing works
Zhang, X., Li, N., Zhang, G., Li, J., Liu, Y., Wang, M., & Ren, X. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128282248231205105408 · Cited by 12 · see citing works
IκB-kinase-ε in the tumor microenvironment is essential for the progression of gastric cancer
Geng, B., Zhang, C., Wang, C., Che, Y., Mu, X., Pan, J., Xu, C., Shi, H., Yang, J., Zhao, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20778 · Cited by 11 · see citing works
Self-citationGregorio, E. D., Miolo, G., Saorin, A., Steffan, A., & Corona, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115574 · Cited by 11 · see citing works
The Crucial Roles of Intermediate Metabolites in Cancer
Huang, S., Wang, Z., & Zhao, L. (2021) · Cancer Management and Research · doi:10.2147/cmar.s321433 · Cited by 11 · see citing works
Selection signature analysis reveals genes underlying sheep milking performance
Yuan, Z., Li, W., Li, F., & Yue, X. (2019) · Archives animal breeding/Archiv für Tierzucht · doi:10.5194/aab-62-501-2019 · Cited by 10 · see citing works
Álvarez-González, E., & Sierra, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169054 · Cited by 10 · see citing works
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
Zhelev, Z., Sumiyoshi, A., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Cancers · doi:10.3390/cancers14040871 · Cited by 10 · see citing works
Turano, M., Vicidomini, R., Cammarota, F., D’Agostino, V., Duraturo, F., Izzo, P., & Rosa, M. D. (2023) · Biomedicines · doi:10.3390/biomedicines11051428 · Cited by 8 · see citing works
Succinate Regulates Endothelial Mitochondrial Function and Barrier Integrity
Atallah, R., Gindlhuber, J., Platzer, W., Rajesh, R., & Heinemann, Á. (2024) · Antioxidants · doi:10.3390/antiox13121579 · Cited by 8 · see citing works
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis
Rajesh, R., Mooslechner, A. A., Schweighöfer, H., Pahernik, S., Lanz, I., Atallah, R., Platzer, W., Aigner, C., Benazzo, A., Angiari, S., et al. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00286.2024 · Cited by 8 · see citing works
Emerging roles of the metabolite succinate in bone-related diseases
Wu, Z., Dai, Q., Wang, Y., Wu, N., Wang, C., & Shi, J. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2400406 · Cited by 11 · see citing works
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors
Sui, Q., Yang, H., Hu, Z., Jin, X., Chen, Z., Jiang, W., & Sun, F. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03783-2 · Cited by 8 · see citing works
Moyon, A., Garrigue, P., Balasse, L., Fernandez-Sauze, S., Brige, P., Bouhlel, A., Hache, G., Dignat‐George, F., Taïeb, D., & Guillet, B. A. (2021) · Cells · doi:10.3390/cells10040795 · Cited by 8 · see citing works
Klid, S., Algaba‐Chueca, F., Maymó‐Masip, E., Ballesteros, M., Inglés, M., Guarque, A., Vilanova, N., Prats, A., Kulovic‐Sissawo, A., Weiß, E., et al. (2025) · The Journal of Physiology · doi:10.1113/jp288010 · Cited by 7 · see citing works
Lee, S.-Y., Kwon, J., & Lee, K. (2021) · Oncology Reports · doi:10.3892/or.2021.7998 · Cited by 7 · see citing works
The Impact of Krebs Cycle Intermediates on the Endocrine System and Immune System: A Comparison
Arneth, B. M. (2023) · Endocrines · doi:10.3390/endocrines4010016 · Cited by 5 · see citing works
Development and Characterization of Potent Succinate Receptor Fluorescent Tracers
Ciba, M., Dibnah, B., Hudson, B. D., & Ulven, E. R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00552 · Cited by 6 · see citing works
Jiang, B., Zhang, Y., She, C., Zhao, J., Zhou, K., Zuo, Z., Zhou, X., Wang, P., & Dong, Q. (2017) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2017.07.010 · Cited by 5 · see citing works
Diagnostic Investigation of Lesions Associated with Succinate Dehydrogenase Defects
Taïeb, D., Timmers, H. J. L. M., & Pacák, K. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0586-3710 · Cited by 4 · see citing works
Biomarkers related to m6A and succinic acid metabolism in papillary thyroid carcinoma
Li, M.-Y., Fu, X., Zhou, T., & Han, H. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01975-8 · Cited by 3 · see citing works
RNA sequencing‑based identification of potential targets in acute myeloid leukemia: A case report
El-Masry, O. S., Al‑Amri, A., Alqatari, A., & Alsamman, K. (2020) · Biomedical Reports · doi:10.3892/br.2020.1349 · Cited by 3 · see citing works
Metabolic pathways involved in retinal angiogenesis: Molecular mechanisms and therapeutic targets
Zhao, M., Zhu, H., Zhou, Y.-K., Nie, Z., Liu, Y., Wang, M., Zhou, W., Zhang, R., & Shen, W. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110752 · Cited by 2 · see citing works
Vascular changes and their implications in lipedema
Al-Ghadban, S., Guo, Y., Juśkiewicz, Z. J., Crescenzi, R. L., Li, X., Isakson, B. E., & Hollenbeck, S. T. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1819443 · Cited by 2 · see citing works
Rewiring tumor metabolism: heterogeneity, oncometabolites, and adaptive plasticity
Yang, J., Zhou, C. C., Kumar, S. V., Shay, C., & Teng, Y. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00795-z · Cited by 2 · see citing works
Self-citationSDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients
Zeng, R., Fan, X., Yang, J. B., Chen, F., Li, J., Wen, W. X., Liu, J., Lv, M., Feng, X., Zhao, X., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00685-4 · Cited by 2 · see citing works
Self-citation
- Authors
- Mu, X., Zhao, T., Xu, C., Shi, W., Geng, B., Shen, J., Zhang, C., Pan, J., Yang, J., Hu, S., Lv, Y., Wen, H., & You, Q.
- Affiliations
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Department of Drug Screening and Evaluation, Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, Jiangsu 210023, China
- Department of Biotherapy, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210011, China
- Corresponding author
- Mu, Xianmin
- Zhao, Ting
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2017-01-04
- Volume
- 8
- Issue
- 8
- Pages
- 13174-13185
- ISSN
- 1949-2553 (ISSN-L)
- PMC
- PMC5355086
- OpenAlex
- W2569614793
- Cited by
- 124
- References
- 35
- Citations by year
- 2026: 11 · 2025: 10 · 2024: 16 · 2023: 14 · 2022: 12 · 2021: 18 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 10
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Oncotarget (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- succinic acid, oncometabolites, tumor angiogenesis, gastric cancer, GPR91, STAT3, ERK1/2, VEGF expression, succinate dehydrogenase mutations, endothelial cell proliferation, cancer metabolism, tumor microenvironment, hypoxia
- MeSH terms
- Animals, Cell Line, Cells, Cultured, Embryo, Nonmammalian, Enzyme-Linked Immunosorbent Assay, Humans, Microscopy, Fluorescence, Stomach Neoplasms, Succinates, Zebrafish, Immunoblotting, Gene Expression, Neovascularization, Physiologic, Mitogen-Activated Protein Kinase 1, Reverse Transcriptase Polymerase Chain Reaction, Animals, Genetically Modified, RNA Interference, Vascular Endothelial Growth Factor A, Receptors, G-Protein-Coupled, Cell Line, Tumor, Mitogen-Activated Protein Kinase 3, STAT3 Transcription Factor, Human Umbilical Vein Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
